MedTech News

.................... by Andrew Celentano

Catheter-directed clot treatment cuts early collapse risk in pulmonary embolism trial

An acute pulmonary embolism occurs when a blood clot blocks one or more vessels in the lung. In patients at moderate or high risk, the blockage can impair the heart’s ability to pump blood through the lungs to such an extent that it becomes life-threatening. About 15% of those affected die as a result of acute pulmonary embolism. Blood-clot-dissolving medications, known as thrombolytics, can effectively dissolve vascular blockages. However, they increase the risk of severe bleeding, particularly in the brain. For this reason, they are generally used only in the most severe cases.

Read More »

Placing battery tech directly on tissue to deliver lithium ions for targeted pain relief

A new study from the University of Chicago taps an ingredient most often used in the lithium-ion batteries that power our devices to open new avenues in biomedical technology. Lithium plays vital roles in the body, but taking it orally can have unwanted side effects—so a pair of UChicago chemistry labs teamed up to find a way to deliver lithium only to the exact places where it’s needed.

Read More »

Sign up for Blog Updates